DNA damage response signaling pathways as important targets for combination therapy and chemotherapy sensitization in osteosarcoma-Reference-Cited by-同舟云学术

DNA damage response signaling pathways as important targets for combination therapy and chemotherapy sensitization in osteosarcoma

Published:2022-04-05 Issue:5 Volume:237 Page:2374-2386
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:Journal Cellular Physiology

Author:

Alemi Forough¹,Malakoti Faezeh¹,Vaghari‐Tabari Mostafa¹^ORCID,Soleimanpour Jafar²,Shabestani Nazila¹,Sadigh Aydin R.¹,Khelghati Nafiseh³,Asemi Zatollah⁴^ORCID,Ahmadi Yasin⁵^ORCID,Yousefi Bahman¹^ORCID

Affiliation:

1. Department of Biochemistry and Clinical Laboratories, Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran

2. Department of Orthopedics Surgery, Shohada Teaching Hospital Tabriz University of Medical Sciences Tabriz Iran

3. Molecular Medicine Research Center Tabriz University of Medical Sciences Tabriz Iran

4. Research Center for Biochemistry and Nutrition in Metabolic Diseases Kashan University of Medical Sciences Kashan Iran

5. Department of Medical Laboratory Sciences, Faculty of Science Komar University of Science and Technology Soleimania Kurdistan Region Iraq

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.30721

Reference105 articles.

1. Mutant p53 gain of oncogenic function: In vivo evidence, mechanism of action and its clinical implications;Adhikari A. S.;Fukuoka Igaku Zasshi. Fukuoka Acta Medica,2009

2. Preparation and in-vitro evaluation of pH-responsive cationic cyclodextrin coated magnetic nanoparticles for delivery of methotrexate to the Saos-2 bone cancer cells

3. Molecular mechanisms involved in DNA repair in human cancers: An overview of PI3k/Akt signaling and PIKKs crosstalk

4. Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies

5. miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long noncoding RNAs as potential targets for overcoming chemoresistance in upper gastrointestinal cancers;Biomedicine & Pharmacotherapy;2024-10

2. Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. METTL3-mediated m6A modification of LINC00520 confers glycolysis and chemoresistance in osteosarcoma via suppressing ubiquitination of ENO1;Cancer Letters;2024-08

4. Discovery of a selective TRF2 inhibitor FKB04 induced telomere shortening and senescence in liver cancer cells;Acta Pharmacologica Sinica;2024-03-04

5. Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma;Journal of Bone Oncology;2024-02